Cardiovascular Disease Research:One Phase Ahead of Alzheimer’s Studies?

By: Robert C. Cupelo, MD Principal Investigator For everyone involved in neurological disease research, the last two years have brought about major advances in our understanding of Alzheimer’s disease and related neurodegenerative disorders. Along with the discovery of new avenues for effective therapies, we now have, for the first time, proven disease modifying treatments. And … Read more

Understanding Fatty Liver Disease

Nathan Hamm, DC, FNP-C. In 2023 a group of over 200 physicians, public health experts, and industry leaders from around the globe voted to rename non-alcoholic fatty liver disease or NAFLD to metabolic dysfunction-associated steatotic liver disease or MASLD.  The goal was to update outdated nomenclature and better reflect the metabolic nature of the disease.  … Read more

Healthcare Organizations Very Vulnerable to Cyberattacks

By: William Ecenbarger Like most other organizations, healthcare facilities have moved toward total digitization. The major benefit of this change is that it has provided an efficient way of sharing patient records among healthcare professionals. Compared to paper-based records, electronic health records require less workforce, time, and physical storage. However, this shift has created a … Read more

Lippes Mathias LLP Combines With Syracuse-Based Health Care Firm CCB Law

Lippes Mathias LLP Combines with Syracuse-Based Health Care Firm CCBLaw, Expands  Lippes’ National Footprint to Include Every Major City in New York The combination creates one of the largest New York health care teams outside of New York City. Lippes Mathias today announced it has combined with CCBLaw, a Syracusebased law firm with a respected … Read more

Paramedicine: Creating a first line of access and follow-up in our communities

By: Kathryn Ruscitto, Advisor Definition: “Community paramedicine is a relatively new and evolving healthcare model. It allows paramedics and emergency medical technicians (EMTs) to operate in expanded roles by assisting with public health and primary healthcare and preventive services to underserved populations in the community.” Rural Health Information Hub Recently I wrote about new models … Read more

Velocity Clinical Research Syracuse Our focus on Alzheimer’s Disease Research

Robert C. Cupelo, MD, Principal Investigator Estimated to currently affect over 6.2 million Americans and expected to increase as the population ages, Alzheimer’s disease is a devastating illness, not only for patients, but also for their family and caregivers. In addition, the condition disproportionately affects underserved medical communities, including low-income populations and people of color, … Read more